These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 12473463)

  • 1. Solution structure of a circular-permuted variant of the potent HIV-inactivating protein cyanovirin-N: structural basis for protein stability and oligosaccharide interaction.
    Barrientos LG; Louis JM; Ratner DM; Seeberger PH; Gronenborn AM
    J Mol Biol; 2003 Jan; 325(1):211-23. PubMed ID: 12473463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Solution structure of a cyanovirin-N:Man alpha 1-2Man alpha complex: structural basis for high-affinity carbohydrate-mediated binding to gp120.
    Bewley CA
    Structure; 2001 Oct; 9(10):931-40. PubMed ID: 11591348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dissecting carbohydrate-Cyanovirin-N binding by structure-guided mutagenesis: functional implications for viral entry inhibition.
    Barrientos LG; Matei E; Lasala F; Delgado R; Gronenborn AM
    Protein Eng Des Sel; 2006 Dec; 19(12):525-35. PubMed ID: 17012344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Computational models explain the oligosaccharide specificity of cyanovirin-N.
    Fujimoto YK; Terbush RN; Patsalo V; Green DF
    Protein Sci; 2008 Nov; 17(11):2008-14. PubMed ID: 18809850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design and initial characterization of a circular permuted variant of the potent HIV-inactivating protein cyanovirin-N.
    Barrientos LG; Louis JM; Hung J; Smith TH; O'Keefe BR; Gardella RS; Mori T; Boyd MR; Gronenborn AM
    Proteins; 2002 Feb; 46(2):153-60. PubMed ID: 11807943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atomic mapping of the interactions between the antiviral agent cyanovirin-N and oligomannosides by saturation-transfer difference NMR.
    Sandström C; Berteau O; Gemma E; Oscarson S; Kenne L; Gronenborn AM
    Biochemistry; 2004 Nov; 43(44):13926-31. PubMed ID: 15518540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potent inhibition of HIV-1 fusion by cyanovirin-N requires only a single high affinity carbohydrate binding site: characterization of low affinity carbohydrate binding site knockout mutants.
    Chang LC; Bewley CA
    J Mol Biol; 2002 Apr; 318(1):1-8. PubMed ID: 12054763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The domain-swapped dimer of cyanovirin-N contains two sets of oligosaccharide binding sites in solution.
    Barrientos LG; Gronenborn AM
    Biochem Biophys Res Commun; 2002 Nov; 298(4):598-602. PubMed ID: 12408994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The potent anti-HIV protein cyanovirin-N contains two novel carbohydrate binding sites that selectively bind to Man(8) D1D3 and Man(9) with nanomolar affinity: implications for binding to the HIV envelope protein gp120.
    Bewley CA; Otero-Quintero S
    J Am Chem Soc; 2001 May; 123(17):3892-902. PubMed ID: 11457139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and characterization of peptides that bind to cyanovirin-N, a potent human immunodeficiency virus-inactivating protein.
    Han Z; Simpson JT; Fivash MJ; Fisher R; Mori T
    Peptides; 2004 Apr; 25(4):551-61. PubMed ID: 15165709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multisite and multivalent binding between cyanovirin-N and branched oligomannosides: calorimetric and NMR characterization.
    Shenoy SR; Barrientos LG; Ratner DM; O'Keefe BR; Seeberger PH; Gronenborn AM; Boyd MR
    Chem Biol; 2002 Oct; 9(10):1109-18. PubMed ID: 12401495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structures of the complexes of a potent anti-HIV protein cyanovirin-N and high mannose oligosaccharides.
    Botos I; O'Keefe BR; Shenoy SR; Cartner LK; Ratner DM; Seeberger PH; Boyd MR; Wlodawer A
    J Biol Chem; 2002 Sep; 277(37):34336-42. PubMed ID: 12110688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective interactions of the human immunodeficiency virus-inactivating protein cyanovirin-N with high-mannose oligosaccharides on gp120 and other glycoproteins.
    Shenoy SR; O'Keefe BR; Bolmstedt AJ; Cartner LK; Boyd MR
    J Pharmacol Exp Ther; 2001 May; 297(2):704-10. PubMed ID: 11303061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Solution and crystal structures of a sugar binding site mutant of cyanovirin-N: no evidence of domain swapping.
    Matei E; Furey W; Gronenborn AM
    Structure; 2008 Aug; 16(8):1183-94. PubMed ID: 18682220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Solution structure of cyanovirin-N, a potent HIV-inactivating protein.
    Bewley CA; Gustafson KR; Boyd MR; Covell DG; Bax A; Clore GM; Gronenborn AM
    Nat Struct Biol; 1998 Jul; 5(7):571-8. PubMed ID: 9665171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Computational study of the dynamics of mannose disaccharides free in solution and bound to the potent anti-HIV virucidal protein cyanovirin.
    Margulis CJ
    J Phys Chem B; 2005 Mar; 109(8):3639-47. PubMed ID: 16851402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conformational gating of dimannose binding to the antiviral protein cyanovirin revealed from the crystal structure at 1.35 A resolution.
    Fromme R; Katiliene Z; Fromme P; Ghirlanda G
    Protein Sci; 2008 May; 17(5):939-44. PubMed ID: 18436959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Designed "Nested" Dimer of Cyanovirin-N Increases Antiviral Activity.
    Woodrum BW; Maxwell J; Allen DM; Wilson J; Krumpe LR; Bobkov AA; Hill RB; Kibler KV; O'Keefe BR; Ghirlanda G
    Viruses; 2016 Jun; 8(6):. PubMed ID: 27275831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atomic mapping of the sugar interactions in one-site and two-site mutants of cyanovirin-N by NMR spectroscopy.
    Sandström C; Hakkarainen B; Matei E; Glinchert A; Lahmann M; Oscarson S; Kenne L; Gronenborn AM
    Biochemistry; 2008 Mar; 47(12):3625-35. PubMed ID: 18311923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyanovirin-N defines a new class of antiviral agent targeting N-linked, high-mannose glycans in an oligosaccharide-specific manner.
    Bolmstedt AJ; O'Keefe BR; Shenoy SR; McMahon JB; Boyd MR
    Mol Pharmacol; 2001 May; 59(5):949-54. PubMed ID: 11306674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.